Article
Multidisciplinary consensus on optimising the detection of NTRK gene alterations in tumours
23 Feb 2021
Abstract excerpt
The recent identification of rearrangements of neurotrophic tyrosine receptor kinase (NTRK) genes and the development of specific fusion protein inhibitors, such as larotrectinib and entrectinib, have revolutionised the diagnostic and clinical management of patients presenting with tumours with these alterations. Tumours that harbour NTRK fusions are found in both adults and children; and they are either rare...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
